TABLE 2:

Clinical characteristics of patients with acute ischemic stroke for whom angiography showed reocclusion after initial recanalization

Patient No.	Age (yr)/Sex	Initial NIHSS Score	Site and Initial Grade^* of Occlusion	ACT (s)	Treatment before Reocclusion	Treatment for Reocclusion^†	Final Grade^b of Occlusion	Outcome^d
1	76/M	26	MCA, 3A	269	Reteplase (3 U), snare (n = 1)	Reteplase (1U), snare (n = 1), angioplasty (n = 1)	2	Death
2	84/M	18	MCA, 3A	252	Reteplase (3 U)	Reteplase (1 U)	1	Death
3	87/M	21	MCA, 3B	251	Reteplase (2 U), snare (n = 1), angioplasty (n = 2)	Reteplase (1 U), angioplasty (n = 1)	2	Death
4	68/M	32	ICA, 5	255	Reteplase (3 U), snare (n = 1)	Angioplasty (n = 1), 2.5 × 12-mm S660 stent (n = 1)	1	Death
5	50/F	26	MCA, 3A	NA	Reteplase (3 U), angioplasty (n = 1)	Reteplase (1 U), angioplasty (n = 1)	2	Death
6	83/M	14	MCA, 3A	250	Reteplase (3 U), angioplasty (n = 1)	Reteplase (2 U), snare (n = 1), 2.25 × 13-mm Bx VELOCITY stent (n = 1)	3A	mRS 4
7	73/M	30	BA, 4B	NA	Reteplase (3 U), angioplasty (n = 1)	Reteplase (1 U), snare (n = 1)	4A	Death
8	75/F	20	ICA, 4A	257	Reteplase (2 U), snare (n = 1)	Reteplase (2 U), snare (n = 1), angioplasty (n = 1)	2	mRS 5

Note.—NIHSS indicates National Institutes of Health Stroke Scale; ACT, activated coagulation time; M, male; F, female; MCA, middle cerebral artery; ICA, internal carotid artery; BA, basilar artery; NA, not available; mRS, modified Rankin scale.
* Grading system from Qureshi AI (7).
† S660 stents were manufactured by Guidant, Temecula, CA; Bx VELOCITY stents were manufactured by Cordis, Miami Lakes, FL.
‡ mRS scores were determined at follow-up 1 to 3 months after thrombolysis.